These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 1371018)

  • 1. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
    Greenberg PL
    Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
    Ganser A; Hoelzer D
    Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
    Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
    Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
    Ganser A; Hoelzer D
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of hematopoietic growth factors].
    Robak T
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
    [No Abstract]   [Full Text] [Related]  

  • 7. Hematopoietic growth factor therapy of myelodysplastic syndromes.
    Arcenas AG; Vadhan-Raj S
    Leuk Lymphoma; 1993; 11 Suppl 2():65-9. PubMed ID: 7510197
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
    Hast R; Bernell P
    Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of bone marrow transplantation in the treatment of myelodysplastic syndromes.
    Schultz AB; Geller RB; Hillyer CD
    J Hematother; 1995 Aug; 4(4):323-34. PubMed ID: 7489147
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.
    Hast R; Eriksson M; Jakovleva K
    Pol Arch Med Wewn; 1998 Feb; 99(2):144-9. PubMed ID: 9686516
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of hematopoietic growth factors].
    Krusius T
    Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of hematopoietic growth factors].
    Elonen E
    Duodecim; 1995; 111(8):733-40. PubMed ID: 8681833
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical use of growth factors in the myelodysplastic syndromes.
    Stein RS
    Am J Med Sci; 1994 May; 307(5):360-7. PubMed ID: 7513498
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hematopoietic growth factors. Current status of therapy].
    Hiddemann W
    Internist (Berl); 1994 Apr; 35(4):395-400. PubMed ID: 7515381
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematopoietic growth factors in autologous bone marrow transplantation.
    Miller AM
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hematopoietic growth factors].
    Robak T
    Postepy Hig Med Dosw; 1991; 45(6):461-96. PubMed ID: 1726024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do haemopoietic growth factors increase the efficacy of aggressive therapy of ANLL in elderly patients?
    Mandelli F; Petti MC
    Hematol Oncol; 1993; 11 Suppl 1():9-11. PubMed ID: 7683626
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.
    Herrmann F; Brugger W; Kanz L; Mertelsmann R
    Semin Oncol; 1992 Aug; 19(4):422-31. PubMed ID: 1380732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.